BACKGROUND: Radiotherapy (RT) plays an important role in the multidisciplinary management of Ewing's Sarcoma (ES), especially in unresectable cases. AIM: Assessment of efficacy of RT in terms of local control in pediatric patients with primary ES of bone. MATERIALS AND METHODS: Thirty-six patients younger than 17 years old with ES treated with combined RT and chemotherapy with (N = 14) or without (N = 22) prior surgery from 1981 to 2008 were retrospectively reviewed. Since 1995, they were all treated according to the Spanish Society of Pediatric Oncology protocol (55.5% cases). Those patients received vincristine, ifosfamide, doxorubicin and etoposide. The TNM classification was as follows: 17 T1, 18 T2 and 1 T3; 36 N0; 29 M0, 5 M1a and 2 M1b. Analysis was stratified by treatment: definitive RT or pre/postoperative RT. RESULTS: The 36 patients (21 male; 15 female) had a median age of 10 years (range 2-17 years). Median follow-up of living patients was 105 months. The 2-year local control (LC) rate for all patients was 88%. Five-year LC rates for patients treated with definitive and pre/postoperative RT were 91% and 86%, respectively. Two-year overall survival and disease-free survival rates for all patients were 68% and 66%, respectively. Low phosphatase alkaline levels and local and distant recurrences were significantly predictive of worse prognosis (P = 0.021, P = 0.011, P = 0.007, respectively). CONCLUSION: Radiotherapy with and without surgery is a highly effective local treatment option in the multidisciplinary management of ES in pediatric patients.
BACKGROUND: Radiotherapy (RT) plays an important role in the multidisciplinary management of Ewing's Sarcoma (ES), especially in unresectable cases. AIM: Assessment of efficacy of RT in terms of local control in pediatric patients with primary ES of bone. MATERIALS AND METHODS: Thirty-six patients younger than 17 years old with ES treated with combined RT and chemotherapy with (N = 14) or without (N = 22) prior surgery from 1981 to 2008 were retrospectively reviewed. Since 1995, they were all treated according to the Spanish Society of Pediatric Oncology protocol (55.5% cases). Those patients received vincristine, ifosfamide, doxorubicin and etoposide. The TNM classification was as follows: 17 T1, 18 T2 and 1 T3; 36 N0; 29 M0, 5 M1a and 2 M1b. Analysis was stratified by treatment: definitive RT or pre/postoperative RT. RESULTS: The 36 patients (21 male; 15 female) had a median age of 10 years (range 2-17 years). Median follow-up of living patients was 105 months. The 2-year local control (LC) rate for all patients was 88%. Five-year LC rates for patients treated with definitive and pre/postoperative RT were 91% and 86%, respectively. Two-year overall survival and disease-free survival rates for all patients were 68% and 66%, respectively. Low phosphatase alkaline levels and local and distant recurrences were significantly predictive of worse prognosis (P = 0.021, P = 0.011, P = 0.007, respectively). CONCLUSION: Radiotherapy with and without surgery is a highly effective local treatment option in the multidisciplinary management of ES in pediatric patients.
Entities:
Keywords:
Ewing's Sarcoma; Local control; Radiotherapy
Authors: M E Nesbit; E A Gehan; E O Burgert; T J Vietti; A Cangir; M Tefft; R Evans; P Thomas; F B Askin; J M Kissane Journal: J Clin Oncol Date: 1990-10 Impact factor: 44.544
Authors: J Dunst; S Ahrens; M Paulussen; C Rübe; W Winkelmann; A Zoubek; D Harms; H Jürgens Journal: Int J Radiat Oncol Biol Phys Date: 1998-09-01 Impact factor: 7.038
Authors: J F Kuttesch; L H Wexler; R B Marcus; D Fairclough; L Weaver-McClure; M White; L Mao; T F Delaney; C B Pratt; M E Horowitz; L E Kun Journal: J Clin Oncol Date: 1996-10 Impact factor: 44.544
Authors: P Rosito; A F Mancini; R Rondelli; M E Abate; A Pession; L Bedei; G Bacci; P Picci; M Mercuri; P Ruggieri; G Frezza; M Campanacci; G Paolucci Journal: Cancer Date: 1999-08-01 Impact factor: 6.860
Authors: Robert B Marcus Jr; B Hudson Berrey; John Graham-Pole; Nancy Price Mendenhall; Mark T Scarborough Journal: Clin Orthop Relat Res Date: 2002-04 Impact factor: 4.176
Authors: Holcombe E Grier; Mark D Krailo; Nancy J Tarbell; Michael P Link; Christopher J H Fryer; Douglas J Pritchard; Mark C Gebhardt; Paul S Dickman; Elizabeth J Perlman; Paul A Meyers; Sarah S Donaldson; Sheila Moore; Aaron R Rausen; Teresa J Vietti; James S Miser Journal: N Engl J Med Date: 2003-02-20 Impact factor: 91.245
Authors: P Okunieff; X Wang; P Rubin; J N Finkelstein; L S Constine; I Ding Journal: Int J Radiat Oncol Biol Phys Date: 1998-11-01 Impact factor: 7.038
Authors: S S Donaldson; M Torrey; M P Link; A Glicksman; L Gilula; F Laurie; J Manning; J Neff; W Reinus; E Thompson; J J Shuster Journal: Int J Radiat Oncol Biol Phys Date: 1998-08-01 Impact factor: 7.038
Authors: Florian Pohlig; Ulrich Lenze; Heinrich M L Muhlhofer; Florian W Lenze; Johannes Schauwecker; Carolin Knebel; Tanja Zimmermann; Peter Herschbach Journal: In Vivo Date: 2017 May-Jun Impact factor: 2.155
Authors: Jose Luis Lopez; Concepcion Pérez; Catalina Marquez; Patricia Cabrera; Jose Maria Perez; Gema Lucia Ramirez; Rafael Ordoñez; Juan Manuel Praena-Fernandez; Maria Jose Ortiz Journal: Rep Pract Oncol Radiother Date: 2011-05-20